Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 35.88 USD -2.84%
Market Cap: 2.9B USD
Have any thoughts about
Verona Pharma PLC?
Write Note

Relative Value

The Relative Value of one VRNA stock under the Base Case scenario is 16.3 USD. Compared to the current market price of 35.88 USD, Verona Pharma PLC is Overvalued by 55%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VRNA Relative Value
Base Case
16.3 USD
Overvaluation 55%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
19
vs Industry
0
Median 3Y
11.3
Median 5Y
0
Industry
2.6
Forward
138
vs History
vs Industry
Median 3Y
-17.8
Median 5Y
-11
Industry
23
Forward
-21
vs History
vs Industry
Median 3Y
-23.4
Median 5Y
-23.4
Industry
17.8
vs History
vs Industry
Median 3Y
-30.6
Median 5Y
-30.6
Industry
25.4
vs History
1
vs Industry
9
Median 3Y
5.8
Median 5Y
5.8
Industry
2.2
vs History
19
vs Industry
0
Median 3Y
7.7
Median 5Y
0
Industry
2.8
Forward
127.9
vs History
4
vs Industry
0
Median 3Y
0
Median 5Y
0
Industry
5.4
vs History
vs Industry
Median 3Y
-13.9
Median 5Y
-7.8
Industry
13.7
vs History
vs Industry
Median 3Y
-13.8
Median 5Y
-7.7
Industry
17.2
Forward
-13.8
vs History
vs Industry
Median 3Y
-19.4
Median 5Y
-19.4
Industry
16.5
vs History
vs Industry
Median 3Y
-19.4
Median 5Y
-19.4
Industry
19.3
vs History
6
vs Industry
2
Median 3Y
33.9
Median 5Y
27.4
Industry
2

Multiples Across Competitors

VRNA Competitors Multiples
Verona Pharma PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Verona Pharma PLC
NASDAQ:VRNA
2.9B USD 518.3 -19 -17.7 -17.6
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
758.2B USD 18.5 90.9 48.9 54.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
367.6B USD 4.2 25 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
250.1B USD 4 20.6 10.4 12.5
CH
Roche Holding AG
SIX:ROG
208.5B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.3 169.3 253.7
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
UK
Verona Pharma PLC
NASDAQ:VRNA
Average P/E: 33.4
Negative Multiple: -19
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25
-22%
US
Merck & Co Inc
NYSE:MRK
20.6
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.3
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A

See Also

Discover More
Back to Top